newsfilter
← Latest News
GlobeNewswire·

BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

  • BioStem Technologies Inc. (NASDAQ: BSEM) announced management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on September 14, 2026.
  • The company's fireside chat is scheduled for Friday, September 11, 2026, at 7:00 AM ET.
  • Live & archived webcasts of the fireside chat will be accessible via the "investors" section at ir.biostemtechnologies.com.
  • BioStem is a publicly traded biomedical innovator focused on developing, manufacturing & commercializing perinatal tissue allograft solutions.
  • The company utilizes proprietary processing technologies including BioRetain®, CryoTek® & SteriTek® to preserve natural tissue properties.
  • BioStem's quality systems are accredited by the Association for Advancing Tissue and Biologics (AATB) in compliance with cGTP & cGMP standards.
  • The company's product portfolio includes the Neox®, Clarix®, VENDAJE® & American Amnion™ lines.
  • Contact information is provided for Investor Relations (Philip Trip Taylor, Gilmartin) & Public Relations (Jennifer Horton, Relevance).